Enhanced bypass of PD-L1 translation reduces the therapeutic response to mTOR kinase inhibitors

Biochemistry, Genetics and Molecular Biology

• PD-L1 100%
• Mechanistic Target of Rapamycin 100%
• Internal Ribosome Entry Site 33%
• Mammalian Target of Rapamycin 8%
• Binding Protein 8%
• Tumor-Infiltrating Lymphocytes 8%
• Immune Checkpoints 8%
• Cancer Cell 8%
• Upregulation 8%
• Targeted Therapy 8%